Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2008-04-14

FDA Approved: AMOXAPINE — Supplemental Application (Actavis Pharma, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Amoxapine by Actavis Pharma, Inc. The submission status indicates approval (AP).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amoxapine (Amoxapine)

Snippet

SUPPL AP for AMOXAPINE (AMOXAPINE)